Browsing Category

63928 posts
SONGMICS HOME Collaborates with Rise Above Foundation in 'Start Above' Initiative to Create Dream Homes for Young Adults

SONGMICS HOME Collaborates with Rise Above Foundation in 'Start Above' Initiative to Create Dream Homes for Young Adults

BOSTON, Jan. 3, 2024 /PRNewswire/ — Global leading online furniture brand SONGMICS…
Global Times: China practices wise foreign policy in managing relations

Global Times: China practices wise foreign policy in managing relations

BEIJING, Jan. 3, 2024 /PRNewswire/ — Editor’s Note: In 2023, the world…
Chengdu Hi-tech Zone Jiaozi Avenue Metaverse District Opens on the 1st Day of the New Year

Chengdu Hi-tech Zone Jiaozi Avenue Metaverse District Opens on the 1st Day of the New Year

CHENGDU, China, Jan. 3, 2024 /PRNewswire/ — On the evening of January…
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases

Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases

INGELHEIM, Germany, MÖLNDAL, Sweden and KUNSHAN, China, Jan. 3, 2024 /PRNewswire/ — Suzhou…
Emeren Group Releases 2022 Environmental, Social and Governance Report

Emeren Group Releases 2022 Environmental, Social and Governance Report

STAMFORD, Conn., Jan. 3, 2024 /PRNewswire/ — Emeren Group Ltd ("Emeren" or…
Outlook Quarter 4/2023

Outlook Quarter 4/2023

SCB EIC revised 2023 growth forecast to 2.6% due to lower Q3 GDP, government spending, and tourist arrivals. 2024 economy to grow at 3.0% with rising exports and private investment. Concerns about slow recovery and uncertainties. Proposes “four enhancing policies” to address structural issues.
Teleperformance and De La Salle-CSB partners for deaf inclusion in the workplace

Teleperformance and De La Salle-CSB partners for deaf inclusion in the workplace

Teleperformance Philippines, the country’s largest Great Place to Work company, has partnered…
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A

Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A

SHANGHAI, Jan. 3, 2024 /PRNewswire/ — Belief BioMed Group (BBM), an industry-leading…